Adjuvant therapy for stages I and II breast cancer.
Henderson
I C
IC
Dana-Farber Cancer Institute, Boston, Massachusetts.
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D011788:Quality of Life; D013629:Tamoxifen / Q000009:adverse effects / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D013629:Tamoxifen